MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Nutritional status and quality of life in patients with Parkinson’s disease in a tertiary hospital in Northeast Mexico

    I.E. Estrada, P. Ancer, H.J. Villarreal, C. Lopez, J. Rocha, A. Treviño, J.J. Peña, D. Ortiz (Monterrey, Mexico)

    Objective: The objective of this study was to determine the quality of life and nutritional status of patients with PD at the University Hospital Jose…
  • 2016 International Congress

    Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients

    S. Klanbut, S. Wongwiwatthananukit, C. Suthisisang, R. Bhidayasiri, S. Phattanarudee (Bangkok, Thailand)

    Objective: To determine the prevalence of OH and identify risk factors associated with OH in Thai PD patients. Background: Orthostatic hypotension (OH) represents one of…
  • 2016 International Congress

    Prevalence and risk factors for orthostatic hypotension in early PD

    C. McDonald, R.A. Lawson, G.W. Duncan, T.K. Khoo, D.J. Brooks, R.A. Barker, A.J. Yarnall, D.J. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To identify the prevalence of orthostatic hypotension (OH) in early Parkinson's disease (PD) and identify clinical features associated with greater postural drop in BP…
  • 2016 International Congress

    Impact of autonomic dysfunction on disease progression and survival in Parkinson’s disease

    E. De Pablo-Fernandez, C. Tur, T. Revesz, J.L. Holton, T.T. Warner (London, United Kingdom)

    Objective: To determine how autonomic dysfunction influences disease progression and survival in Parkinson's disease (PD). Background: Autonomic dysfunction is a common feature in PD and…
  • 2016 International Congress

    Neurocognitive domains of impulsivity in Parkinson’s disease (PD) and the effects of dopaminergic replacement therapy (DRT)

    M. Sousa, N. Canário, F. Moreira, C. Duarte, M. Castelo-Branco, C. Januário (Coimbra, Portugal)

    Objective: To investigate whether 3 different domains of impulsive behavior(reactive, proactive and cognitive) are differentially affected in medicated PD as compared with healthy controls. We…
  • 2016 International Congress

    Association of mood and affective disorders with pain in Parkinson’s disease

    J.S. Kim, W. Jang, J. Park, E. Oh, J. Youn, J.W. Cho (Seoul, Korea)

    Objective: We aimed to compare the severity of depression and anxiety in Parkinson's disease (PD) patients with pain and without pain, and demonstrate the relationship…
  • 2016 International Congress

    Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease: Meta-analysis of individual participant data from seven prospective observational studies

    F. Yang, N.L. Pedersen, W. Ye, Z. Liu, M. Norberg, L. Forsgren, Y. Trolle Lagerros, R. Bellocco, L. Alfredsson, A. Knutsson, J.H. Jansson, R. Galanti, A.C.J. Lager, M. Araghi, M. Lundberg, C. Magnusson, K. Wirdefeldt (Stockholm, Sweden)

    Objective: To investigate the associations between use of Swedish moist smokeless tobacco (snus) and risk of Parkinson's disease (PD). Background: Cigarette smoking is associated with…
  • 2016 International Congress

    Comorbid conditions associated with Parkinson´s disease: A longitudinal study

    D. Santos García, E. Suarez Castro, I. Expósito, T. de Deus, C. Tuñas, D. Núñez Arias, Á. Aneiros, M. López Fernández, J. Naveiro, J. Abella, M.A. Llaneza, V. Vilas, M. Macías (Ferrol, Spain)

    Objective: (1)To study what comorbid conditions were present at baseline and 3 years later in a cohort of Spanish PD patients and (2) to analyze…
  • 2016 International Congress

    Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants

    S.M. Goldman, F. Kamel, C. Meng, M. Korell, D.M. Umbach, J. Hoppin, G.W. Ross, C. Marras, M. Kasten, A. Chade, K. Comyns, D. Sandler, A. Blair, C.M. Tanner (San Francisco, CA, USA)

    Objective: Determine whether variants in the xenobiotic efflux membrane transporter p-glycoprotein gene (ABCB1, p-gp, MDR1) modify the association of rotenone and PD. Background: Use of…
  • 2016 International Congress

    Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease

    I.F. Shih, K.C. Paul, Y. Bordelon, J.M. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: To assess whether and how pre- and postdiagnosis physical activities affect motor function, cognition, and depression among Parkinson's disease (PD) patients. Background: Physical activities…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley